Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02692339 · COMPLETED
Trial details
- NCT number
- NCT02692339
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-02-25
- Primary completion
- 2018-12-12
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.